Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
At SpringSource, we bring a harm reduction lens to this work
Recalculate only after reading the new label and confirming it with the pharmacy
In the drugs best showing so far, the ATTAIN-1 trial, people taking orforglipron lost on average 12.4% of their baseline weight, a notch below the roughly 14% weight loss seen in similar trials of Novo Nordisks injectable Wegovy and also below the typical results seen with Eli Lillys tirzepatide, a dual GLP-1/GIP medication
Stay well hydrated : Sip water regularly throughout the day
US$ 21.49
US$ 26.67
US$ 29.52
US$ 23.54
